Overview of Global Orthobiologics Market
Orthobiologics encompass a broad range of technologies with a biological or biochemical component. Examples include biologic factors delivered through a device, bone graft materials, cell therapies, and resorbable scaffolds to reinforce soft tissue. Rise in usage of orthobiologics products and orthopedic devices, and the integration of biology and biochemistry in the treatment of bone and soft tissue injuries are driving the orthobiologics market. Orthobiologics are medications that speed up the body’s natural healing process. They can help repair osteoarthritis damage as well as accelerate the recovery of strained muscles, tendons, and ligaments. Orthobiologics are made with components that are naturally found in the human body. Rise in prevalence of inflammatory conditions such as osteoarthritis and tendinitis along with increase in participation in a sports activity that can lead to ligament or muscle injury in teenagers and young adults is expected to drive the global orthobiologics market during the forecast period. Orthobiologics, which has the potential to accelerate the healing process for pain and injuries, provides solutions and hope for people who want to live a pain-free life.
Request a Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1747
Surge in Sports Injuries to Drive Global Orthobiologics Market
Sports injuries have become a major concern for athletes. The musculoskeletal system, which consists of the muscles, tendons, ligaments, fascia, nerves, bones, and tissues, is involved in sports injuries. Falls, excessive exertion, and fractures are the primary causes of these injuries. Lower and upper extremities suffer the majority of sports-related injuries and muscle injuries. Orthobiologics, such as stem cells, are used to treat common, acute, and chronic sports injuries. Year-round participation in a single sport is the most significant cause of increase in youth injuries. Rugby, combat sports, field hockey, basketball, and handball account for the most number of hand injuries.
In the last few decades, there has been an increase in sports participation by children and adolescents at an early age in the U.S. There has also been a rise in specialization in sports at a very early age. This trend has contributed to the patterns of injuries seen in young athletes. Injuries previously observed in mature athletes are now being reported in young athletes. According to a study published by the National Library of Medicine, 3.5 million youth under the age of 15 receive medical care each year in the U.S. for injuries sustained during sports practice.
Request For Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1747
Increase in Demand for Non-surgical Treatments for Osteoarthritis to Propel Viscosupplements Segment
In terms of product, the viscosupplements segment held significant market share in 2021. Increase in demand for non-surgical treatments for osteoarthritis, rise in prevalence of lifestyle-induced disorders, and advancements in hyaluronic acid-based therapies are expected to drive the viscosupplements segment during the forecast period. Viscosupplements demonstrate clinical efficacy and is the most effective treatment for knee osteoarthritis. Osteoarthritis is the most common joint disorder in the U.S., affecting nearly 27 million people. Osteoarthritis of the knee alone affects 10% of men and 13% of women over the age of 60. Viscosupplementation can significantly reduce pain while improving joint mobility and function, making daily activities and even athletic or strenuous exercise less painful. Manufacturers of viscosupplementation devices are striving to develop and get approval for new medicines to treat osteoarthritis of the elbow, hip, and knee.
Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1747
Rise in Number of Spinal and Sports-related Injuries to Boost Demand for Spinal Fusion Devices
The spinal fusion segment accounted for the largest share of the global orthobiologics market in 2021. The segment is expected to be driven by the increase in number of spinal injuries and sports-related injuries during the forecast period. Demand for spinal fusion devices has been rising across the globe. Majority of spinal cord injuries are caused by avoidable incidences such as car accidents, falls, or violence. Traumatic spinal injury (TSI) occurs when bony, ligamentous, and/or neurologic structures of the spinal column are injured and result in significant morbidity and mortality.
Provision of Majority of Orthopedic Surgeries to Drive Hospitals Segment
In terms of end-user, the hospitals segment is projected to account for a major share of the global orthobiologics market during the forecast period. Orthopedic surgery is performed in hospitals on various parts such as the shoulder, ankle, hip, knee, wrists, elbow, and spine, depending on the type of injury or damage. Knee joint replacement, arthroscopy, pediatric orthopedic, and other minimally invasive orthopedic surgeries are the most commonly recommended procedures. Hence, the hospitals segment is likely to capture significant market share during the forecast period. Surgeries were traditionally performed in hospitals; however, advances in technology, anesthesia, and pain control now allow physicians to perform certain procedures in an orthopedic clinic center. This is projected to drive the orthopedic clinics segment in the next few years.
Request Report Methodology: https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=1747
Analysis of Key Players in Global Orthobiologics Market
The global orthobiologics market is consolidated, with the presence of small number of leading players. Expansion of product portfolio and mergers & acquisitions are the key strategies adopted by the leading players in the global orthobiologics market. Alphatec Spine, Inc., Integra Life Sciences, DePuy Synthes, Seikagaku Corporation, Arthrex, RTI Surgical, Inc., MTF Biologics, Exactech, Inc., Johnson & Johnson, Sanofi, and Stryker are the prominent players operating in the global orthobiologics market.
Key Developments in Global Orthobiologics Market
- In March 2022, MTF Biologics and Orthofix Medical, Inc. extended their orthobiologics collaboration. The agreement extends Orthofix’s exclusive marketing rights to the Trinity allograft line till 2032 and includes an expansion agreement for the development of a demineralized bone matrix (DBM) that Orthofix will market under the Legacy brand name.
- In November 2020, OssDsign expanded into the large and rapidly growing orthobiologics segment, thereby taking the first transformative step toward becoming a broader orthopedic player. OssDsign expanded its product portfolio with the addition of a next-generation nanosynthetic bone graft substitute designed to treat skeletal defects.
- In March 2016, Zimmer Biomet entered into an exclusive global distribution agreement with recently formed upstart CelgenTek Innovations to distribute its fracture fixation system and a bone-void filler
Ask References: https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=1747
Each of these players has been profiled in the orthobiologics market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
More Trending Reports by Transparency Market Research:
Endoscope Washer Disinfector Market – https://www.transparencymarketresearch.com/endoscope-washerdisinfectors-market.html
Analytical Standards Market – https://www.transparencymarketresearch.com/analytical-standards-market.html
Biobanking Market – https://www.transparencymarketresearch.com/biobanking-market.html
Vitamin D Testing Market – https://www.transparencymarketresearch.com/vitamin-d-testing-market.html
Laboratory Gas Generators Market – https://www.transparencymarketresearch.com/laboratory-gas-generators-market.html
Critical Limb Ischemia Treatment Market – https://www.transparencymarketresearch.com/critical-limb-ischemia-treatment.html
Mice Model Technologies Market – https://www.transparencymarketresearch.com/mice-model-technologies-market.html
Motion Preservation Devices Market – https://www.transparencymarketresearch.com/motion-preservation-devices-market.html
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update – https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
